Evidence map›Paper›PMID 25522419›Full record

ArticleThe international journal of neuropsychopharmacology2014

Chronic desipramine prevents acute stress-induced reorganization of medial prefrontal cortex architecture by blocking glutamate vesicle accumulation and excitatory synapse increase.

Nicoletta Nava, Giulia Treccani, Nico Liebenberg, Fenghua Chen, Maurizio Popoli, Gregers Wegener, Jens Randel Nyengaard

Open access · goldAbstract read
In one paragraph

Article in The international journal of neuropsychopharmacology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 33 citations in OpenAlex.

  1. Challenges and rewards of in vivo synaptic density imaging, and its application to the study of depression.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024
    Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Modulation of the activity ofNeuropsychiatric disease and treatment · 2017
    Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Nicoletta NavaStereology and Electron Microscopy Laboratory, Centre for Stochastic Geometry and Advanced Bioimaging, Aarhus University Hospital, Aarhus, Denmark (Drs Nava, Chen, and Nyengaard); Translational Neuropsychiatry Unit, Department of Clinical Medicine, Aarhus University, Risskov, Denmark (Drs Nava, Treccani, Liebenberg, Chen, and Wegener); Pharmaceutical Research Center of Excellence, School of Pharmacy, North-West University, Potchefstroom, South Africa (Dr Wegener); Laboratory of Neuropsychopharmacology and Functional Neurogenomics, Dipartimento di Scienze Farmacologiche e Biomolecolari and Center of Excellence on Neurodegenerative Diseases, Università degli Studi di Milano, Milano, Italy (Drs Treccani and Popoli). nicoletta.nava@ki.au.dk.
Giulia TreccaniStereology and Electron Microscopy Laboratory, Centre for Stochastic Geometry and Advanced Bioimaging, Aarhus University Hospital, Aarhus, Denmark (Drs Nava, Chen, and Nyengaard); Translational Neuropsychiatry Unit, Department of Clinical Medicine, Aarhus University, Risskov, Denmark (Drs Nava, Treccani, Liebenberg, Chen, and Wegener); Pharmaceutical Research Center of Excellence, School of Pharmacy, North-West University, Potchefstroom, South Africa (Dr Wegener); Laboratory of Neuropsychopharmacology and Functional Neurogenomics, Dipartimento di Scienze Farmacologiche e Biomolecolari and Center of Excellence on Neurodegenerative Diseases, Università degli Studi di Milano, Milano, Italy (Drs Treccani and Popoli).
Nico LiebenbergStereology and Electron Microscopy Laboratory, Centre for Stochastic Geometry and Advanced Bioimaging, Aarhus University Hospital, Aarhus, Denmark (Drs Nava, Chen, and Nyengaard); Translational Neuropsychiatry Unit, Department of Clinical Medicine, Aarhus University, Risskov, Denmark (Drs Nava, Treccani, Liebenberg, Chen, and Wegener); Pharmaceutical Research Center of Excellence, School of Pharmacy, North-West University, Potchefstroom, South Africa (Dr Wegener); Laboratory of Neuropsychopharmacology and Functional Neurogenomics, Dipartimento di Scienze Farmacologiche e Biomolecolari and Center of Excellence on Neurodegenerative Diseases, Università degli Studi di Milano, Milano, Italy (Drs Treccani and Popoli).
Fenghua ChenStereology and Electron Microscopy Laboratory, Centre for Stochastic Geometry and Advanced Bioimaging, Aarhus University Hospital, Aarhus, Denmark (Drs Nava, Chen, and Nyengaard); Translational Neuropsychiatry Unit, Department of Clinical Medicine, Aarhus University, Risskov, Denmark (Drs Nava, Treccani, Liebenberg, Chen, and Wegener); Pharmaceutical Research Center of Excellence, School of Pharmacy, North-West University, Potchefstroom, South Africa (Dr Wegener); Laboratory of Neuropsychopharmacology and Functional Neurogenomics, Dipartimento di Scienze Farmacologiche e Biomolecolari and Center of Excellence on Neurodegenerative Diseases, Università degli Studi di Milano, Milano, Italy (Drs Treccani and Popoli).
Maurizio PopoliStereology and Electron Microscopy Laboratory, Centre for Stochastic Geometry and Advanced Bioimaging, Aarhus University Hospital, Aarhus, Denmark (Drs Nava, Chen, and Nyengaard); Translational Neuropsychiatry Unit, Department of Clinical Medicine, Aarhus University, Risskov, Denmark (Drs Nava, Treccani, Liebenberg, Chen, and Wegener); Pharmaceutical Research Center of Excellence, School of Pharmacy, North-West University, Potchefstroom, South Africa (Dr Wegener); Laboratory of Neuropsychopharmacology and Functional Neurogenomics, Dipartimento di Scienze Farmacologiche e Biomolecolari and Center of Excellence on Neurodegenerative Diseases, Università degli Studi di Milano, Milano, Italy (Drs Treccani and Popoli).
Gregers WegenerStereology and Electron Microscopy Laboratory, Centre for Stochastic Geometry and Advanced Bioimaging, Aarhus University Hospital, Aarhus, Denmark (Drs Nava, Chen, and Nyengaard); Translational Neuropsychiatry Unit, Department of Clinical Medicine, Aarhus University, Risskov, Denmark (Drs Nava, Treccani, Liebenberg, Chen, and Wegener); Pharmaceutical Research Center of Excellence, School of Pharmacy, North-West University, Potchefstroom, South Africa (Dr Wegener); Laboratory of Neuropsychopharmacology and Functional Neurogenomics, Dipartimento di Scienze Farmacologiche e Biomolecolari and Center of Excellence on Neurodegenerative Diseases, Università degli Studi di Milano, Milano, Italy (Drs Treccani and Popoli).
Jens Randel NyengaardStereology and Electron Microscopy Laboratory, Centre for Stochastic Geometry and Advanced Bioimaging, Aarhus University Hospital, Aarhus, Denmark (Drs Nava, Chen, and Nyengaard); Translational Neuropsychiatry Unit, Department of Clinical Medicine, Aarhus University, Risskov, Denmark (Drs Nava, Treccani, Liebenberg, Chen, and Wegener); Pharmaceutical Research Center of Excellence, School of Pharmacy, North-West University, Potchefstroom, South Africa (Dr Wegener); Laboratory of Neuropsychopharmacology and Functional Neurogenomics, Dipartimento di Scienze Farmacologiche e Biomolecolari and Center of Excellence on Neurodegenerative Diseases, Università degli Studi di Milano, Milano, Italy (Drs Treccani and Popoli).
Aarhus University · DKNorth-West University · ZA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAlthough a clear negative influence of chronic exposure to stressful experiences has been repeatedly demonstrated, the outcome of acute stress on key brain regions has only just started to be elucidated. Although it has been proposed that acute stress may produce enhancement of brain plasticity and that antidepressants may prevent such changes, we still lack ultrastructural evidence that acute stress-induced changes in neurotransmitter physiology are coupled with structural synaptic modifications.

methodsRats were pretreated chronically (14 days) with desipramine (10mg/kg) and then subjected to acute foot-shock stress. By means of serial section electron microscopy, the structural remodeling of medial prefrontal cortex glutamate synapses was assessed soon after acute stressor cessation and stress hormone levels were measured.

resultsFoot-shock stress induced a remarkable increase in the number of docked vesicles and small excitatory synapses, partially and strongly prevented by desipramine pretreatment, respectively. Acute stress-induced corticosterone elevation was not affected by drug treatment.

conclusionsSince desipramine pretreatment prevented the stress-induced structural plasticity but not the hormone level increase, we hypothesize that the preventing action of desipramine is located on pathways downstream of this process and/or other pathways. Moreover, because enhancement of glutamate system remodeling may contribute to overexcitation dysfunctions, this aspect could represent a crucial component in the pathophysiology of stress-related disorders.

Indexed as

Prefrontal CortexAnimalsAntidepressive Agents, TricyclicCorticosteroneDesipramineDisease Models, AnimalElectroshockGlutamic AcidMaleMicroscopy, Electron, TransmissionModels, NeurologicalRatsRats, Sprague-DawleyStress, PsychologicalSynapsesSynaptic VesiclesAntidepressive Agents, TricyclicCorticosteroneDesipramineGlutamic AcidVesicular Glutamate Transport Protein 1desipramineglutamatestresssynapse

Identifiers

PMID25522419
PMCPMC4360240
OpenAlexW2175043856

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.